Acute delirium after withdrawal of amantadine in Parkinson's disease
- PMID: 9596005
- DOI: 10.1212/wnl.50.5.1456
Acute delirium after withdrawal of amantadine in Parkinson's disease
Abstract
We present three patients who, after long-term therapy with amantadine (4 to 18 years), experienced an acute delirium with confusion, disorientation, agitation, and paranoia on withdrawal. These patients had Parkinson's disease for 5 to 29 years; mean age was 73 years. All had a history of varying degrees of dementia and transient hallucinations in the past. Adjustment of other medications was ineffective in improving their condition and no other cause was found. Only with reinstitution of amantadine did the patients return to baseline status (usually within days).
Comment in
-
New lessons from old drugs: amantadine and Parkinson's disease.Neurology. 1998 May;50(5):1211-2. doi: 10.1212/wnl.50.5.1211. Neurology. 1998. PMID: 9595964 Clinical Trial. No abstract available.
-
Acute delirium after withdrawal of amantadine in Parkinson's disease.Neurology. 1999 May 12;52(8):1720-1. doi: 10.1212/wnl.52.8.1717-d. Neurology. 1999. PMID: 10331717 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous